AbbVie Inc. 8-K

What Happened

• AbbVie Inc. filed Form 8‑K on May 12, 2026 reporting the results of its Annual Meeting of Stockholders held May 8, 2026. Stockholders elected AbbVie’s Class II directors, ratified Ernst & Young LLP as auditor, approved the advisory "say-on-pay" vote, and voted on two governance proposals (amendment to eliminate supermajority voting and a proposal to require an independent chair), both of which were not approved under the terms reported.

Key Details

• Director elections (Class II, terms expiring 2029):
  • Jennifer L. Davis — For: 1,216,558,754; Against: 89,839,329; Abstain: 2,680,369; Broker non‑votes: 239,399,581
  • Melody B. Meyer — For: 1,284,771,578; Against: 22,470,074; Abstain: 1,836,800; Broker non‑votes: 239,399,581
  • Robert A. Michael — For: 1,221,224,370; Against: 85,865,852; Abstain: 1,988,230; Broker non‑votes: 239,399,581
  • Frederick H. Waddell — For: 1,225,237,825; Against: 81,747,033; Abstain: 2,093,594; Broker non‑votes: 239,399,581
• Auditor ratification: Ernst & Young LLP was ratified for 2026 — For: 1,522,575,012; Against: 23,766,564; Abstain: 2,136,457.
• Advisory executive compensation (say‑on‑pay): Approved — For: 1,228,615,745; Against: 69,336,359; Abstain: 11,126,348; Broker non‑votes: 239,399,581.
• Governance proposals:
  • Management proposal to amend the certificate of incorporation to eliminate supermajority voting was not approved (For: 1,290,990,023; Against: 14,896,119; Abstain: 3,192,310; Broker non‑votes: 239,399,581) — the filing states it did not receive the required level of support.
  • Stockholder proposal to require an independent chair was not approved — For: 515,626,009; Against: 787,253,970; Abstain: 6,198,473; Broker non‑votes: 239,399,581.

Why It Matters

• These results confirm AbbVie’s board slate and retention of its auditor for 2026, providing continuity in governance and financial oversight. The advisory approval of executive pay signals majority investor support for compensation practices, but remains non‑binding. The failure of the supermajority amendment (despite substantial “For” votes) and rejection of the independent‑chair proposal mean existing charter voting thresholds and current chair structure remain in place—important for shareholders concerned about governance and shareholder rights.